Fiera Capital Corp Alkermes Plc. Transaction History

Fiera Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 02, 2018	SELL	$40.56 - $51.36 $23.8 Million - $30.2 Million	-587,466 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$53.61 - $67.26 $968,411 - $1.21 Million	-18,064 Reduced 2.98%	587,466 $34.1 Million
Q4 2017 Feb 09, 2018	SELL	$47.69 - $55.39 $1.49 Million - $1.73 Million	-31,273 Reduced 4.91%	605,530 $33.1 Million
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $31.3 Million - $34.7 Million	636,803	636,803 $32.4 Million

363

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.72B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.